You have 9 free searches left this month | for more free features.

City

Charleston (1)

New Orleans (1)

Condition

Carcinoma, Hepatocellular (1)

Cholangiocarcinoma (1)

Cholangiocarcinoma Non-resectable (1)

Cholangiocarcinoma, Extrahepatic (1)

Cholangiocarcinoma, Intrahepatic (1)

Cholangiocarcinoma, Perihilar (1)

Diffuse Large B Cell Lymphoma (1)

Kaposi Sarcoma (1)

Overall Status

Withdrawn (2)

Available (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

RedHill Biopharma Limited (2)

Medical University of South Carolina (1)

Collaborator

Apogee Biotechnology Corporation (2)

Louisiana State University Health Sciences Center in New Orleans (1)

National Cancer Institute (NCI) (1)

Intervention

abc294640 (3)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (2)

Expanded Access (1)

abc294640

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Cholangiocarcinoma, Cholangiocarcinoma Non-resectable, Cholangiocarcinoma, Perihilar Trial (ABC294640)

Available

Cholangiocarcinoma
+4 more

ABC294640

(no location specified)

Mar 14, 2022

Carcinoma, Hepatocellular Trial in Charleston (ABC294640)

Withdrawn

Carcinoma, Hepatocellular

ABC294640

Charleston, South Carolina

Medical University of South Carolina

Sep 10, 2019

Diffuse Large B Cell Lymphoma, Kaposi Sarcoma Trial in New Orleans (ABC294640)

Withdrawn

Diffuse Large B Cell Lymphoma
Kaposi Sarcoma

ABC294640

New Orleans, Louisiana

Louisiana State University Health Sciences Center

Dec 5, 2017